We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.71B
AUM Growth
+$351M
Cap. Flow
-$22.1M
Cap. Flow %
-0.6%
Top 10 Hldgs %
21.85%
Holding
5,705
New
584
Increased
2,919
Reduced
1,681
Closed
462

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$127M
2
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$20M
3
PLTR icon
Palantir
PLTR
+$18.3M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$16.7M
5
DEO icon
Diageo
DEO
+$16.3M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$206M
2
META icon
Meta Platforms (Facebook)
META
+$37.5M
3
AMZN icon
Amazon
AMZN
+$35.5M
4
AVGO icon
Broadcom
AVGO
+$34.8M
5
MSFT icon
Microsoft
MSFT
+$29.8M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Financials 11.61%
3 Healthcare 8.42%
4 Industrials 6.72%
5 Consumer Discretionary 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NESR
3351
National Energy Services Reunited Corp
NESR
$3.62B
$31.9K ﹤0.01%
+5,291
New +$32.8K
RYAM icon
3352
Rayonier Advanced Materials
RYAM
$570M
$31.8K ﹤0.01%
8,271
+6,242
+308% +$26.2K
METC icon
3353
Ramaco Resources Class A
METC
$667M
$31.8K ﹤0.01%
2,422
-3,375
-58% -$32.3K
DQ
3354
Daqo New Energy
DQ
$1.01B
$31.7K ﹤0.01%
2,092
+1,871
+847% +$26.6K
INNV icon
3355
InnovAge Holding
INNV
$1.45B
$31.7K ﹤0.01%
8,590
+4,843
+129% +$17K
ATXS
3356
DELISTED
Astria Therapeutics
ATXS
$31.6K ﹤0.01%
5,901
-1,701
-22% -$8.24K
INBX icon
3357
Inhibrx
INBX
$1.42B
$31.6K ﹤0.01%
2,216
+1,347
+155% +$17.4K
OPTU
3358
Optimum Communications Inc
OPTU
$228M
$31.5K ﹤0.01%
14,719
-15,405
-51% -$36.1K
VTEX icon
3359
VTEX
VTEX
$630M
$31.5K ﹤0.01%
4,766
+4,713
+8,892% +$27.7K
RERE
3360
ATRenew
RERE
$1.02B
$31.5K ﹤0.01%
9,503
-3,859
-29% -$10K
GRDN
3361
Guardian Pharmacy Services
GRDN
$2.44B
$31.5K ﹤0.01%
1,476
+917
+164% +$20.7K
HRTX icon
3362
Heron Therapeutics
HRTX
$63.5M
$31.4K ﹤0.01%
15,181
+8,554
+129% +$17.5K
HPK icon
3363
HighPeak Energy
HPK
$947M
$31.4K ﹤0.01%
3,200
+637
+25% +$6.28K
BYAH
3364
Park Ha Biological Technology Co
BYAH
$2.52M
$31.3K ﹤0.01%
+2
New +$13.4K
FTK icon
3365
Flotek Industries
FTK
$1.25B
$31.3K ﹤0.01%
2,121
-1,864
-47% -$21.5K
NPWR icon
3366
NET Power
NPWR
$143M
$31.3K ﹤0.01%
12,674
+6,032
+91% +$12.7K
DNA icon
3367
Ginkgo Bioworks
DNA
$488M
$31.3K ﹤0.01%
2,781
-14,752
-84% -$114K
VRT icon
3368
Vertiv
VRT
$111B
$31.2K ﹤0.01%
243
-4,426
-95% -$430K
IBEX icon
3369
IBEX
IBEX
$482M
$31.2K ﹤0.01%
1,071
+505
+89% +$13.5K
COOK icon
3370
Traeger
COOK
$166M
$31.1K ﹤0.01%
364
+161
+79% +$12.4K
SNDR icon
3371
Schneider National
SNDR
$6.37B
$31.1K ﹤0.01%
1,286
+20
+2% +$465
RNAC icon
3372
Cartesian Therapeutics
RNAC
$264M
$31K ﹤0.01%
2,985
+704
+31% +$7.5K
VIRC icon
3373
Virco
VIRC
$97.2M
$31K ﹤0.01%
3,880
+2,719
+234% +$23.9K
OVLY icon
3374
Oak Valley Bancorp
OVLY
$288M
$30.9K ﹤0.01%
1,134
+751
+196% +$19.1K
CTRN icon
3375
Citi Trends
CTRN
$621M
$30.9K ﹤0.01%
925
+484
+110% +$12.3K
133 134
135
136 137

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2025 Portfolio in Review

As of Q2 2025, Tower Research Capital (TRC) held 5,705 positions worth $3.71B, up 10% from $3.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC)'s Q2 2025 filing shows 584 new, 2,919 increased, 1,681 reduced and 462 closed positions. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M. The largest sale was Invesco QQQ Trust, an estimated $206M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Tower Research Capital (TRC)'s largest Q2 2025 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $127M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $206M.
  • Tower Research Capital (TRC) fully exited iShares S&P 500 Value ETF in Q2 2025, selling an estimated $6.43M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.71B portfolio in Q2 2025.
  • Tower Research Capital (TRC) opened 584 new positions and closed 462 in Q2 2025.
  • Tower Research Capital (TRC)'s portfolio value rose 10% quarter-over-quarter to $3.71B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.